search
Back to results

Propess Versus Prostin for Induction of Labour in Women With Term PROM (PESTIBOR)

Primary Purpose

Premature Rupture of Membranes at Term, Induction of Labour

Status
Unknown status
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Prostaglandin E2 (Propess)
Prostaglandin E2 (Prostin)
Sponsored by
University Medical Centre Maribor
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Premature Rupture of Membranes at Term focused on measuring Induction, PROM, Propess, Prostin

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 18 years or older
  • Gestational age 37 weeks or more
  • Singleton pregnancy
  • Cephalic presentation
  • Unfavorable cervix (BISHOP <6)
  • No contraindications for vaginal delivery
  • Without uterine surgery
  • Without chorioamnionitis

Exclusion Criteria:

  • Age less than 18 years
  • Multiple gestation
  • Previous cesarean section
  • Suspected intraamniotic infection
  • Any contraindication to vaginal delivery
  • Bishop score >7
  • Pathological ctg

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Propess Vaginal Delivery System

    Prostin Tablet

    Arm Description

    Propess - Prostaglandin E2 Vaginal Delivery System. Slow intravaginal release of 10 mg dinoprostone at a rate of 0.3 mg/h.

    Prostaglandin E2 Vaginal Tablet 3 mg dinoprostone

    Outcomes

    Primary Outcome Measures

    Induction to Delivery Interval
    Induction to Onset of labor Interval

    Secondary Outcome Measures

    Frequency of Cesarean Sections
    Frequency of Failed Induction

    Full Information

    First Posted
    January 26, 2021
    Last Updated
    February 9, 2021
    Sponsor
    University Medical Centre Maribor
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04743297
    Brief Title
    Propess Versus Prostin for Induction of Labour in Women With Term PROM
    Acronym
    PESTIBOR
    Official Title
    Labour Induction With the Propess Vaginal Delivery System vs. Labour Induction With the Prostin Vaginal Tablet in Case of a Prelabour Rupture of Membranes. PESTIBOR Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    March 2021 (Anticipated)
    Primary Completion Date
    January 2023 (Anticipated)
    Study Completion Date
    January 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University Medical Centre Maribor

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Premature rupture of membranes (PROM) at term is a rupture that occurs at term (> 37 weeks) before the start of labor. The purpose of the study was to compare the safety and efficacy of two agents used in induction of labor in women with term PROM Propess (Controlled release dinoprostone, Vaginal Delivery System) and Prostin E2 (Dinoprostone vaginal Tablet). Women will be randomised to two treatment groups. Although some studies support efficacy of the Propess for cervical ripening at term in induction of labor with intact membranes, it has not been well studied in women with PROM at term.
    Detailed Description
    The study is going to include all pregnant women with in-term PROM (after week 37 of pregnancy) without contractions if they meet the inclusion criteria. If the cervix is still non-inducible after 4-6 hours and there are no contractions, the medication to be administered to them will be determined by means of computer randomization. The success rate of induction with Propess vs. Prostin tablets will be compared. Soon after PROM, there can be the onset of contractions and cervix dilation that lead to childbirth. In case of some pregnant women, there are no contractions and cervix dilation even after the event despite PROM and water breaking. If the status remains unchanged, the risk of intrauterine infection, fetus infection, and later on an infection of the newborn increases. The expecting mother can also eventually lose hope for a successful vaginal birth and starts thinking about having a caesarean delivery. To avoid that, the investigators use medications that accelerate the onset of vaginal birth in clinical practice. The investigators know several ways to induce labour after PROM. References give no clear and reliable data on the best approach. The investigators can use medications such as oxytocin, dinoprostone, or misoprostol. Our ward has been using Prostin 3 mg (dinoprostone) vaginal tablets to induce labour in case of PROM for several years. They have proven to be an efficient and safe procedure in our clinical practice. Propess is used for the induction of labor with intact membranes. Based on the information from references and according to our experience, the medication is highly effective and safe, as well as easy to use. Our study aims at establishing whether it can also be used with pregnant women with PROM.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Premature Rupture of Membranes at Term, Induction of Labour
    Keywords
    Induction, PROM, Propess, Prostin

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Model Description
    Randomized Controlled Trial
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    526 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Propess Vaginal Delivery System
    Arm Type
    Active Comparator
    Arm Description
    Propess - Prostaglandin E2 Vaginal Delivery System. Slow intravaginal release of 10 mg dinoprostone at a rate of 0.3 mg/h.
    Arm Title
    Prostin Tablet
    Arm Type
    Active Comparator
    Arm Description
    Prostaglandin E2 Vaginal Tablet 3 mg dinoprostone
    Intervention Type
    Drug
    Intervention Name(s)
    Prostaglandin E2 (Propess)
    Other Intervention Name(s)
    dinoprostone
    Intervention Description
    Propess - The vaginal insert is removed 24 h after the application. It is only to be removed earlier in case of the onset of active labour or at the occurrence of hyperstimulation.
    Intervention Type
    Drug
    Intervention Name(s)
    Prostaglandin E2 (Prostin)
    Other Intervention Name(s)
    dinoprostone
    Intervention Description
    Prostin - 3 mg vaginal tablet is placed in the posterior vaginal fornix. Dose can be repeated every 8 hours till onset of active labour or the occurrence of hyper-stimulation.
    Primary Outcome Measure Information:
    Title
    Induction to Delivery Interval
    Time Frame
    24 hours
    Title
    Induction to Onset of labor Interval
    Time Frame
    24 hours
    Secondary Outcome Measure Information:
    Title
    Frequency of Cesarean Sections
    Time Frame
    24 hours
    Title
    Frequency of Failed Induction
    Time Frame
    24 hours

    10. Eligibility

    Sex
    Female
    Gender Based
    Yes
    Gender Eligibility Description
    Women
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Age 18 years or older Gestational age 37 weeks or more Singleton pregnancy Cephalic presentation Unfavorable cervix (BISHOP <6) No contraindications for vaginal delivery Without uterine surgery Without chorioamnionitis Exclusion Criteria: Age less than 18 years Multiple gestation Previous cesarean section Suspected intraamniotic infection Any contraindication to vaginal delivery Bishop score >7 Pathological ctg
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Veronika Anzeljc
    Phone
    + 386 2 321 21 73
    Email
    veronika.anzeljc@ukc-mb.si
    First Name & Middle Initial & Last Name or Official Title & Degree
    Faris Mujezinović
    Phone
    + 386 2 321 24 08
    Email
    faris.mujezinovic@ukc-mb.si
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Veronika Anzeljc
    Organizational Affiliation
    Maribor University Medical Centre
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    32005186
    Citation
    Mynarek M, Bjellmo S, Lydersen S, Strand KM, Afset JE, Andersen GL, Vik T. Prelabor rupture of membranes and the association with cerebral palsy in term born children: a national registry-based cohort study. BMC Pregnancy Childbirth. 2020 Jan 31;20(1):67. doi: 10.1186/s12884-020-2751-3.
    Results Reference
    background
    Citation
    National Collaborating Centre for Women's and Children's Health. National Institute for Health and Care Excellence: Clinical Guidelines. Intrapartum Care: Care of Healthy Women and Their Babies During Childbirth. London: National Institute for Health and Care Excellence (UK) Copyright (c) 2014 National Collaborating Centre for Women's and Children's Health.; 2014
    Results Reference
    background
    PubMed Identifier
    8598837
    Citation
    Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, Wang EE, Weston JA, Willan AR. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med. 1996 Apr 18;334(16):1005-10. doi: 10.1056/NEJM199604183341601.
    Results Reference
    background
    PubMed Identifier
    1630743
    Citation
    Zlatnik FJ. Management of premature rupture of membranes at term. Obstet Gynecol Clin North Am. 1992 Jun;19(2):353-64.
    Results Reference
    background
    PubMed Identifier
    30917724
    Citation
    Geethanath RM, Ahmed I, Abu-Harb M, Onwuneme C, McGarry K, Hinshaw K. Intrapartum antibiotics for prolonged rupture of membranes at term to prevent Group B Streptococcal sepsis. J Obstet Gynaecol. 2019 Jul;39(5):619-622. doi: 10.1080/01443615.2018.1550474. Epub 2019 Mar 27.
    Results Reference
    background
    PubMed Identifier
    27423032
    Citation
    Ivars J, Garabedian C, Devos P, Therby D, Carlier S, Deruelle P, Subtil D. Simplified Bishop score including parity predicts successful induction of labor. Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:309-14. doi: 10.1016/j.ejogrb.2016.06.007. Epub 2016 Jul 5.
    Results Reference
    background
    PubMed Identifier
    32585393
    Citation
    Athiel Y, Crequit S, Bongiorno M, Sanyan S, Renevier B. Term prelabor rupture of membranes: Foley catheter versus dinoprostone as ripening agent. J Gynecol Obstet Hum Reprod. 2020 Oct;49(8):101834. doi: 10.1016/j.jogoh.2020.101834. Epub 2020 Jun 22.
    Results Reference
    background
    PubMed Identifier
    31491801
    Citation
    Freret TS, Chacon KM, Bryant AS, Kaimal AJ, Clapp MA. Oxytocin Compared to Buccal Misoprostol for Induction of Labor after Term Prelabor Rupture of Membranes. Am J Perinatol. 2021 Feb;38(3):224-230. doi: 10.1055/s-0039-1696642. Epub 2019 Sep 6.
    Results Reference
    background
    PubMed Identifier
    16929421
    Citation
    Cheung PC, Yeo EL, Wong KS, Tang LC. Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstet Gynecol Scand. 2006;85(9):1128-33. doi: 10.1080/00016340600589636.
    Results Reference
    background
    PubMed Identifier
    31456315
    Citation
    Hu YP, Zhou D, Li M, Wang Y, Wang L, Sun GQ, Xiao M. Use of labor induction with dinoprostone vaginal suppositories in pregnant women with gestational hypertension. J Obstet Gynaecol Res. 2019 Nov;45(11):2185-2192. doi: 10.1111/jog.14092. Epub 2019 Aug 27.
    Results Reference
    background
    PubMed Identifier
    30317521
    Citation
    Shirley M. Dinoprostone Vaginal Insert: A Review in Cervical Ripening. Drugs. 2018 Oct;78(15):1615-1624. doi: 10.1007/s40265-018-0995-2.
    Results Reference
    background
    Citation
    Pajntar M, Lučovnik M. Normalni porod in vodenje poroda. v knjigi Nosečnost in vodenje poroda. Ured. Pajntar M, Novak Antolič Ž, Lučovnik M. Medicinski razgledi 2015. Tretja dopolnjena izdaja. 231-50.
    Results Reference
    background

    Learn more about this trial

    Propess Versus Prostin for Induction of Labour in Women With Term PROM

    We'll reach out to this number within 24 hrs